Advanced search
Publication Cover
Current Eye Research Volume 10, 1991 - Issue 6
Submit an article Journal homepage
34
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Short acting soft mydriatics

R. H. Hammer Center for Drug Design and Delivery, College of Pharmacy, University of Florida, Box J-497, J. Hillis Miller Health Center, Gainesville, FL, 32610, USA
,
W. Wu Center for Drug Design and Delivery, College of Pharmacy, University of Florida, Box J-497, J. Hillis Miller Health Center, Gainesville, FL, 32610, USA
,
J. S. Sastry Center for Drug Design and Delivery, College of Pharmacy, University of Florida, Box J-497, J. Hillis Miller Health Center, Gainesville, FL, 32610, USA
&
N. Bodor Center for Drug Design and Delivery, College of Pharmacy, University of Florida, Box J-497, J. Hillis Miller Health Center, Gainesville, FL, 32610, USA
Pages 565-570 | Received 04 Feb 1991, Accepted 06 May 1991, Published online: 02 Jul 2009

References

  • Jaanus S. D., Pagano V. T., Bartlett J. D. Drugs affecting the autonomic nervous system: cholinergic antagonists. “Clinical Ocular Pharmacology”, J. D. Bartlett. Butterworth Publishers, Boston 1984; 106–130
  • Gambill H. D., Ogle K. N., Kearns T. P. Mydriatic effects of four drugs determined with a pupillograph. Arch. Ophthalmol. 1967; 77: 740–746
  • Gettes B. C., Belmont O. Tropicamide: comparative cycloplegic effects. Arch. Ophthalmol. 1961; 66: 336–340
  • Hammer R. H., Amin K., Gunes Z. E., Brouillette G., Bodor N. Novel soft anticholinergic agents. Drug Des. Deliv. 1988; 2: 207–219
  • Weiner N. Atropine, scopolamine and related antimuscarinic drugs. “The Pharmacological Basis of Therapeutics”, A. G. Gilman, L. S. Goodman, A. Gilman. Macmillan, New York 1980; 6: 120–137
  • Bodor N. Novel approaches to the design of safer drugs: soft drugs and site-specific chemical delivery systems. “Advances in Drug Research”, B. Testa. Academic Press, New York 1984; Vol. 13: 255–331
  • Bodor N., Oshiro Y., Loftsson T., Katovich M., Caldwell M. Soft drugs 6. The application of the inactive metabolite approach for design of soft 8-blockers. Pharm. Res. 1984; 1: 120–125

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.